2019
PDF files containing presentations will be displayed and can be downloaded after clicking on a presentation itself.
DAY 1 (September 26, 2019)
Morning session 1 (9:00–10:30, 2 × 45 min)
Topic 1: ICH M9 – BCS
Henrike Potthast (BfArM, PKWP): ICH M9 – BCS Guideline – overview of comments
Martina Nora Odložilíková (Consultant): ICH M9 – BCS Guideline – industry perspective
Morning session 2 (11:00–12:30, 2 × 45 min)
Topic 2: EMA Scientific Advices
René Anour (AGES): Biosimilar PK trials and an Agency's perspective to EMA Scientific Advice
Nathalie Masson (Unither Pharmaceuticals): EMA Scientific Advices – industry perspective
Afternoon session 1 (13:30–15:00, 2 × 45 min)
Topic 3: ICH M10 – Bioanalytical Method Validation
Philip Timmerman (EBF): ICH M10 – Feedback and comments from the European Bioanalysis Forum
Maria Caturla (Anapharm Bioanalytics): ICH M10 – Bioanalytical Method Validation – industry case studies
Afternoon session 2 (15:30–17:30, 2 × 45 min plus 1 x 30 min)
Topic 4: WEU
Jana Klimasová (SUKL): Well-established use - principles, requirements and case-studies
Marina Feřtek (Consultant): WEU procedures – reflection of reality
Topic 5: Future trends
Alassane Ba (Centre Humanitaire des Métiers de la Pharmacie): Panafrican agency
Day 2 (September 27, 2019)
Morning session 1 (9:00–10:30, 2 × 45 min)
Topic 6: LALA topicals
Flavian Radulescu (Universitatea de Medicina si Farmacie "Carol Davila"): Draft guideline on quality and equivalence of topical products
Volodymyr Stus (Polpharma): Draft guideline on quality and equivalence of topical products – case study
Morning session 2 (11:00–12:30, 3 × 30 min)
Topic 7: Dissolution/development
Jean-Michel Cardot (Université d’Auvergne): Dissolution for specific products e.g. vaginal rings, IVIVC, suspensions
Jiři Hofmann (Zentiva): Simulations – bootstrapping, Q and A
Paulo Paixão (Universidade de Lisboa): Dissolution profile comparison using different statistical approaches – f2 bootstrapping
Afternoon session 1 (13:30–15:30, 2 × 45 min plus 1 x 30 min)
Topic 8: Product specific guidelines/ BE
Susana Almeida (Medicines for Europe): Harmonization of BE requirements – harmonization of reference products
Paola Coppola (MHRA): EMA product specific guidelines
BB team: BioBridges 2019 – concluding remarks